Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00277-015-2412-1 http://scihub22266oqcxt.onion/10.1007/s00277-015-2412-1 26048243/?report=reader!4488459!26048243     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ann+Hematol 2015 ; 94 (8): 1267-76 Nephropedia Template TP {{tp|p=26048243|t=2015. Repurposing medicinal compounds for blood cancer treatment |pdf=|usr=}}{{26048243}} gab.com Text Repurposing medicinal compounds for blood cancer treatment JO: Ann Hematol http://www.kidney.de/pget.php?&tw=1&pmid=26048243 #FOAvip Drug development is being continuously scrutinised for its lack of productivity. Novel drug development is associated with high costs, high failure rates and lengthy development process. These downfalls combined with a huge demand in blood cancer for new therapeutic treatments have led many to consider the method of drug repurposing. Finding new therapeutic indications for already established drug substances is known as redirecting, repositioning, reprofiling, or repurposing of drugs. Off-patent and on-patent drugs can be screened for additional targets and new indications thus bringing them to clinical trials at a faster pace. This approach offers smaller research groups, such as those that are academic based, into the drug development industry. Drug repurposing can make use of previously published data concerning dosage, toxicology and mechanism of activity. Twit Text FOAVip Repurposing medicinal compounds for blood cancer treatment ????Ann Hematol http://www.kidney.de/pget.php?&tw=1&pmid=26048243 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26048243 #FOAvip English Wikipedia <ref>{{Cite pmid|26048243}}</ref> Repurposing medicinal compounds for blood cancer treatment #MMPMID26048243 McCabe B; Liberante F; Mills KI Ann Hematol 2015[Aug]; 94 (8): 1267-76 PMID26048243show ga Drug development is being continuously scrutinised for its lack of productivity. Novel drug development is associated with high costs, high failure rates and lengthy development process. These downfalls combined with a huge demand in blood cancer for new therapeutic treatments have led many to consider the method of drug repurposing. Finding new therapeutic indications for already established drug substances is known as redirecting, repositioning, reprofiling, or repurposing of drugs. Off-patent and on-patent drugs can be screened for additional targets and new indications thus bringing them to clinical trials at a faster pace. This approach offers smaller research groups, such as those that are academic based, into the drug development industry. Drug repurposing can make use of previously published data concerning dosage, toxicology and mechanism of activity. |Animals[MESH] |Antineoplastic Agents/*administration & dosage[MESH] |Benzamides/administration & dosage[MESH] |Drug Delivery Systems/methods/*trends[MESH] |Drug Repositioning/methods/*trends[MESH] |Hematologic Neoplasms/diagnosis/*drug therapy[MESH] |Humans[MESH] |Imatinib Mesylate[MESH] |Piperazines/administration & dosage[MESH] |Pyrimidines/administration & dosage[MESH]Repurposing medicinal compounds for blood cancer treatment (epmc).pdf DeepDyve Pubget Overpricing